Global Radiotheranostic Supply, Demand and Key Producers, 2023-2029
The global Radiotheranostic market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Radiotheranostic demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Radiotheranostic, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Radiotheranostic that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Radiotheranostic total market, 2018-2029, (USD Million)
Global Radiotheranostic total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Radiotheranostic total market, key domestic companies and share, (USD Million)
Global Radiotheranostic revenue by player and market share 2018-2023, (USD Million)
Global Radiotheranostic total market by Type, CAGR, 2018-2029, (USD Million)
Global Radiotheranostic total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Radiotheranostic market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ITM Isotopen Technologien M?nchen AG, Advanced Accelerator Applications, Telix Pharmaceuticals, Theragnostics Ltd., NuView Life Sciences, Jubilant Pharma Limited, Clarity Pharmaceuticals., TransCode Therapeutics, Inc. and Curium SAS, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Radiotheranostic market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Radiotheranostic Market, By Region:
1. How big is the global Radiotheranostic market?
2. What is the demand of the global Radiotheranostic market?
3. What is the year over year growth of the global Radiotheranostic market?
4. What is the total value of the global Radiotheranostic market?
5. Who are the major players in the global Radiotheranostic market?
6. What are the growth factors driving the market demand?
This report studies the global Radiotheranostic demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Radiotheranostic, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Radiotheranostic that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Radiotheranostic total market, 2018-2029, (USD Million)
Global Radiotheranostic total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Radiotheranostic total market, key domestic companies and share, (USD Million)
Global Radiotheranostic revenue by player and market share 2018-2023, (USD Million)
Global Radiotheranostic total market by Type, CAGR, 2018-2029, (USD Million)
Global Radiotheranostic total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Radiotheranostic market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ITM Isotopen Technologien M?nchen AG, Advanced Accelerator Applications, Telix Pharmaceuticals, Theragnostics Ltd., NuView Life Sciences, Jubilant Pharma Limited, Clarity Pharmaceuticals., TransCode Therapeutics, Inc. and Curium SAS, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Radiotheranostic market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Radiotheranostic Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Nuclear Reactors
- Cyclotrons
- Oncology
- Non-Oncology
- ITM Isotopen Technologien M?nchen AG
- Advanced Accelerator Applications
- Telix Pharmaceuticals
- Theragnostics Ltd.
- NuView Life Sciences
- Jubilant Pharma Limited
- Clarity Pharmaceuticals.
- TransCode Therapeutics, Inc.
- Curium SAS
- GE Healthcare Inc.
- Bayer AG
- Lantheus Medical
- Imaging, Inc.
- Novartis AG
- Spectrum Pharmaceuticals, Inc.
- Ipsen S.A.
- Actinium Pharmaceuticals, Inc. (ATNM)
- Nordic Nanovector ASA
- Y-mAbs Therapeutics, Inc.
- Sofie Biosciences, Inc.
- Terumo Corporation
- Sirtex Medical Limited
- Boston Scientific Corporation
- Nihon Medi-Physics
1. How big is the global Radiotheranostic market?
2. What is the demand of the global Radiotheranostic market?
3. What is the year over year growth of the global Radiotheranostic market?
4. What is the total value of the global Radiotheranostic market?
5. Who are the major players in the global Radiotheranostic market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Radiotheranostic Introduction
1.2 World Radiotheranostic Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Radiotheranostic Total Market by Region (by Headquarter Location)
1.3.1 World Radiotheranostic Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Radiotheranostic Market Size (2018-2029)
1.3.3 China Radiotheranostic Market Size (2018-2029)
1.3.4 Europe Radiotheranostic Market Size (2018-2029)
1.3.5 Japan Radiotheranostic Market Size (2018-2029)
1.3.6 South Korea Radiotheranostic Market Size (2018-2029)
1.3.7 ASEAN Radiotheranostic Market Size (2018-2029)
1.3.8 India Radiotheranostic Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Radiotheranostic Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Radiotheranostic Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Radiotheranostic Consumption Value (2018-2029)
2.2 World Radiotheranostic Consumption Value by Region
2.2.1 World Radiotheranostic Consumption Value by Region (2018-2023)
2.2.2 World Radiotheranostic Consumption Value Forecast by Region (2024-2029)
2.3 United States Radiotheranostic Consumption Value (2018-2029)
2.4 China Radiotheranostic Consumption Value (2018-2029)
2.5 Europe Radiotheranostic Consumption Value (2018-2029)
2.6 Japan Radiotheranostic Consumption Value (2018-2029)
2.7 South Korea Radiotheranostic Consumption Value (2018-2029)
2.8 ASEAN Radiotheranostic Consumption Value (2018-2029)
2.9 India Radiotheranostic Consumption Value (2018-2029)
3 WORLD RADIOTHERANOSTIC COMPANIES COMPETITIVE ANALYSIS
3.1 World Radiotheranostic Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Radiotheranostic Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Radiotheranostic in 2022
3.2.3 Global Concentration Ratios (CR8) for Radiotheranostic in 2022
3.3 Radiotheranostic Company Evaluation Quadrant
3.4 Radiotheranostic Market: Overall Company Footprint Analysis
3.4.1 Radiotheranostic Market: Region Footprint
3.4.2 Radiotheranostic Market: Company Product Type Footprint
3.4.3 Radiotheranostic Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Radiotheranostic Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Radiotheranostic Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Radiotheranostic Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Radiotheranostic Consumption Value Comparison
4.2.1 United States VS China: Radiotheranostic Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Radiotheranostic Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Radiotheranostic Companies and Market Share, 2018-2023
4.3.1 United States Based Radiotheranostic Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Radiotheranostic Revenue, (2018-2023)
4.4 China Based Companies Radiotheranostic Revenue and Market Share, 2018-2023
4.4.1 China Based Radiotheranostic Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Radiotheranostic Revenue, (2018-2023)
4.5 Rest of World Based Radiotheranostic Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Radiotheranostic Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Radiotheranostic Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Radiotheranostic Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Nuclear Reactors
5.2.2 Cyclotrons
5.3 Market Segment by Type
5.3.1 World Radiotheranostic Market Size by Type (2018-2023)
5.3.2 World Radiotheranostic Market Size by Type (2024-2029)
5.3.3 World Radiotheranostic Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Radiotheranostic Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Oncology
6.2.2 Non-Oncology
6.3 Market Segment by Application
6.3.1 World Radiotheranostic Market Size by Application (2018-2023)
6.3.2 World Radiotheranostic Market Size by Application (2024-2029)
6.3.3 World Radiotheranostic Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 ITM Isotopen Technologien M?nchen AG
7.1.1 ITM Isotopen Technologien M?nchen AG Details
7.1.2 ITM Isotopen Technologien M?nchen AG Major Business
7.1.3 ITM Isotopen Technologien M?nchen AG Radiotheranostic Product and Services
7.1.4 ITM Isotopen Technologien M?nchen AG Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 ITM Isotopen Technologien M?nchen AG Recent Developments/Updates
7.1.6 ITM Isotopen Technologien M?nchen AG Competitive Strengths & Weaknesses
7.2 Advanced Accelerator Applications
7.2.1 Advanced Accelerator Applications Details
7.2.2 Advanced Accelerator Applications Major Business
7.2.3 Advanced Accelerator Applications Radiotheranostic Product and Services
7.2.4 Advanced Accelerator Applications Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Advanced Accelerator Applications Recent Developments/Updates
7.2.6 Advanced Accelerator Applications Competitive Strengths & Weaknesses
7.3 Telix Pharmaceuticals
7.3.1 Telix Pharmaceuticals Details
7.3.2 Telix Pharmaceuticals Major Business
7.3.3 Telix Pharmaceuticals Radiotheranostic Product and Services
7.3.4 Telix Pharmaceuticals Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Telix Pharmaceuticals Recent Developments/Updates
7.3.6 Telix Pharmaceuticals Competitive Strengths & Weaknesses
7.4 Theragnostics Ltd.
7.4.1 Theragnostics Ltd. Details
7.4.2 Theragnostics Ltd. Major Business
7.4.3 Theragnostics Ltd. Radiotheranostic Product and Services
7.4.4 Theragnostics Ltd. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Theragnostics Ltd. Recent Developments/Updates
7.4.6 Theragnostics Ltd. Competitive Strengths & Weaknesses
7.5 NuView Life Sciences
7.5.1 NuView Life Sciences Details
7.5.2 NuView Life Sciences Major Business
7.5.3 NuView Life Sciences Radiotheranostic Product and Services
7.5.4 NuView Life Sciences Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 NuView Life Sciences Recent Developments/Updates
7.5.6 NuView Life Sciences Competitive Strengths & Weaknesses
7.6 Jubilant Pharma Limited
7.6.1 Jubilant Pharma Limited Details
7.6.2 Jubilant Pharma Limited Major Business
7.6.3 Jubilant Pharma Limited Radiotheranostic Product and Services
7.6.4 Jubilant Pharma Limited Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Jubilant Pharma Limited Recent Developments/Updates
7.6.6 Jubilant Pharma Limited Competitive Strengths & Weaknesses
7.7 Clarity Pharmaceuticals.
7.7.1 Clarity Pharmaceuticals. Details
7.7.2 Clarity Pharmaceuticals. Major Business
7.7.3 Clarity Pharmaceuticals. Radiotheranostic Product and Services
7.7.4 Clarity Pharmaceuticals. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Clarity Pharmaceuticals. Recent Developments/Updates
7.7.6 Clarity Pharmaceuticals. Competitive Strengths & Weaknesses
7.8 TransCode Therapeutics, Inc.
7.8.1 TransCode Therapeutics, Inc. Details
7.8.2 TransCode Therapeutics, Inc. Major Business
7.8.3 TransCode Therapeutics, Inc. Radiotheranostic Product and Services
7.8.4 TransCode Therapeutics, Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 TransCode Therapeutics, Inc. Recent Developments/Updates
7.8.6 TransCode Therapeutics, Inc. Competitive Strengths & Weaknesses
7.9 Curium SAS
7.9.1 Curium SAS Details
7.9.2 Curium SAS Major Business
7.9.3 Curium SAS Radiotheranostic Product and Services
7.9.4 Curium SAS Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Curium SAS Recent Developments/Updates
7.9.6 Curium SAS Competitive Strengths & Weaknesses
7.10 GE Healthcare Inc.
7.10.1 GE Healthcare Inc. Details
7.10.2 GE Healthcare Inc. Major Business
7.10.3 GE Healthcare Inc. Radiotheranostic Product and Services
7.10.4 GE Healthcare Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 GE Healthcare Inc. Recent Developments/Updates
7.10.6 GE Healthcare Inc. Competitive Strengths & Weaknesses
7.11 Bayer AG
7.11.1 Bayer AG Details
7.11.2 Bayer AG Major Business
7.11.3 Bayer AG Radiotheranostic Product and Services
7.11.4 Bayer AG Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Bayer AG Recent Developments/Updates
7.11.6 Bayer AG Competitive Strengths & Weaknesses
7.12 Lantheus Medical
7.12.1 Lantheus Medical Details
7.12.2 Lantheus Medical Major Business
7.12.3 Lantheus Medical Radiotheranostic Product and Services
7.12.4 Lantheus Medical Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Lantheus Medical Recent Developments/Updates
7.12.6 Lantheus Medical Competitive Strengths & Weaknesses
7.13 Imaging, Inc.
7.13.1 Imaging, Inc. Details
7.13.2 Imaging, Inc. Major Business
7.13.3 Imaging, Inc. Radiotheranostic Product and Services
7.13.4 Imaging, Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Imaging, Inc. Recent Developments/Updates
7.13.6 Imaging, Inc. Competitive Strengths & Weaknesses
7.14 Novartis AG
7.14.1 Novartis AG Details
7.14.2 Novartis AG Major Business
7.14.3 Novartis AG Radiotheranostic Product and Services
7.14.4 Novartis AG Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Novartis AG Recent Developments/Updates
7.14.6 Novartis AG Competitive Strengths & Weaknesses
7.15 Spectrum Pharmaceuticals, Inc.
7.15.1 Spectrum Pharmaceuticals, Inc. Details
7.15.2 Spectrum Pharmaceuticals, Inc. Major Business
7.15.3 Spectrum Pharmaceuticals, Inc. Radiotheranostic Product and Services
7.15.4 Spectrum Pharmaceuticals, Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Spectrum Pharmaceuticals, Inc. Recent Developments/Updates
7.15.6 Spectrum Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
7.16 Ipsen S.A.
7.16.1 Ipsen S.A. Details
7.16.2 Ipsen S.A. Major Business
7.16.3 Ipsen S.A. Radiotheranostic Product and Services
7.16.4 Ipsen S.A. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Ipsen S.A. Recent Developments/Updates
7.16.6 Ipsen S.A. Competitive Strengths & Weaknesses
7.17 Actinium Pharmaceuticals, Inc. (ATNM)
7.17.1 Actinium Pharmaceuticals, Inc. (ATNM) Details
7.17.2 Actinium Pharmaceuticals, Inc. (ATNM) Major Business
7.17.3 Actinium Pharmaceuticals, Inc. (ATNM) Radiotheranostic Product and Services
7.17.4 Actinium Pharmaceuticals, Inc. (ATNM) Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Actinium Pharmaceuticals, Inc. (ATNM) Recent Developments/Updates
7.17.6 Actinium Pharmaceuticals, Inc. (ATNM) Competitive Strengths & Weaknesses
7.18 Nordic Nanovector ASA
7.18.1 Nordic Nanovector ASA Details
7.18.2 Nordic Nanovector ASA Major Business
7.18.3 Nordic Nanovector ASA Radiotheranostic Product and Services
7.18.4 Nordic Nanovector ASA Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Nordic Nanovector ASA Recent Developments/Updates
7.18.6 Nordic Nanovector ASA Competitive Strengths & Weaknesses
7.19 Y-mAbs Therapeutics, Inc.
7.19.1 Y-mAbs Therapeutics, Inc. Details
7.19.2 Y-mAbs Therapeutics, Inc. Major Business
7.19.3 Y-mAbs Therapeutics, Inc. Radiotheranostic Product and Services
7.19.4 Y-mAbs Therapeutics, Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Y-mAbs Therapeutics, Inc. Recent Developments/Updates
7.19.6 Y-mAbs Therapeutics, Inc. Competitive Strengths & Weaknesses
7.20 Sofie Biosciences, Inc.
7.20.1 Sofie Biosciences, Inc. Details
7.20.2 Sofie Biosciences, Inc. Major Business
7.20.3 Sofie Biosciences, Inc. Radiotheranostic Product and Services
7.20.4 Sofie Biosciences, Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 Sofie Biosciences, Inc. Recent Developments/Updates
7.20.6 Sofie Biosciences, Inc. Competitive Strengths & Weaknesses
7.21 Terumo Corporation
7.21.1 Terumo Corporation Details
7.21.2 Terumo Corporation Major Business
7.21.3 Terumo Corporation Radiotheranostic Product and Services
7.21.4 Terumo Corporation Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.21.5 Terumo Corporation Recent Developments/Updates
7.21.6 Terumo Corporation Competitive Strengths & Weaknesses
7.22 Sirtex Medical Limited
7.22.1 Sirtex Medical Limited Details
7.22.2 Sirtex Medical Limited Major Business
7.22.3 Sirtex Medical Limited Radiotheranostic Product and Services
7.22.4 Sirtex Medical Limited Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.22.5 Sirtex Medical Limited Recent Developments/Updates
7.22.6 Sirtex Medical Limited Competitive Strengths & Weaknesses
7.23 Boston Scientific Corporation
7.23.1 Boston Scientific Corporation Details
7.23.2 Boston Scientific Corporation Major Business
7.23.3 Boston Scientific Corporation Radiotheranostic Product and Services
7.23.4 Boston Scientific Corporation Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.23.5 Boston Scientific Corporation Recent Developments/Updates
7.23.6 Boston Scientific Corporation Competitive Strengths & Weaknesses
7.24 Nihon Medi-Physics
7.24.1 Nihon Medi-Physics Details
7.24.2 Nihon Medi-Physics Major Business
7.24.3 Nihon Medi-Physics Radiotheranostic Product and Services
7.24.4 Nihon Medi-Physics Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.24.5 Nihon Medi-Physics Recent Developments/Updates
7.24.6 Nihon Medi-Physics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Radiotheranostic Industry Chain
8.2 Radiotheranostic Upstream Analysis
8.3 Radiotheranostic Midstream Analysis
8.4 Radiotheranostic Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Radiotheranostic Introduction
1.2 World Radiotheranostic Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Radiotheranostic Total Market by Region (by Headquarter Location)
1.3.1 World Radiotheranostic Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Radiotheranostic Market Size (2018-2029)
1.3.3 China Radiotheranostic Market Size (2018-2029)
1.3.4 Europe Radiotheranostic Market Size (2018-2029)
1.3.5 Japan Radiotheranostic Market Size (2018-2029)
1.3.6 South Korea Radiotheranostic Market Size (2018-2029)
1.3.7 ASEAN Radiotheranostic Market Size (2018-2029)
1.3.8 India Radiotheranostic Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Radiotheranostic Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Radiotheranostic Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Radiotheranostic Consumption Value (2018-2029)
2.2 World Radiotheranostic Consumption Value by Region
2.2.1 World Radiotheranostic Consumption Value by Region (2018-2023)
2.2.2 World Radiotheranostic Consumption Value Forecast by Region (2024-2029)
2.3 United States Radiotheranostic Consumption Value (2018-2029)
2.4 China Radiotheranostic Consumption Value (2018-2029)
2.5 Europe Radiotheranostic Consumption Value (2018-2029)
2.6 Japan Radiotheranostic Consumption Value (2018-2029)
2.7 South Korea Radiotheranostic Consumption Value (2018-2029)
2.8 ASEAN Radiotheranostic Consumption Value (2018-2029)
2.9 India Radiotheranostic Consumption Value (2018-2029)
3 WORLD RADIOTHERANOSTIC COMPANIES COMPETITIVE ANALYSIS
3.1 World Radiotheranostic Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Radiotheranostic Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Radiotheranostic in 2022
3.2.3 Global Concentration Ratios (CR8) for Radiotheranostic in 2022
3.3 Radiotheranostic Company Evaluation Quadrant
3.4 Radiotheranostic Market: Overall Company Footprint Analysis
3.4.1 Radiotheranostic Market: Region Footprint
3.4.2 Radiotheranostic Market: Company Product Type Footprint
3.4.3 Radiotheranostic Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Radiotheranostic Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Radiotheranostic Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Radiotheranostic Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Radiotheranostic Consumption Value Comparison
4.2.1 United States VS China: Radiotheranostic Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Radiotheranostic Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Radiotheranostic Companies and Market Share, 2018-2023
4.3.1 United States Based Radiotheranostic Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Radiotheranostic Revenue, (2018-2023)
4.4 China Based Companies Radiotheranostic Revenue and Market Share, 2018-2023
4.4.1 China Based Radiotheranostic Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Radiotheranostic Revenue, (2018-2023)
4.5 Rest of World Based Radiotheranostic Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Radiotheranostic Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Radiotheranostic Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Radiotheranostic Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Nuclear Reactors
5.2.2 Cyclotrons
5.3 Market Segment by Type
5.3.1 World Radiotheranostic Market Size by Type (2018-2023)
5.3.2 World Radiotheranostic Market Size by Type (2024-2029)
5.3.3 World Radiotheranostic Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Radiotheranostic Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Oncology
6.2.2 Non-Oncology
6.3 Market Segment by Application
6.3.1 World Radiotheranostic Market Size by Application (2018-2023)
6.3.2 World Radiotheranostic Market Size by Application (2024-2029)
6.3.3 World Radiotheranostic Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 ITM Isotopen Technologien M?nchen AG
7.1.1 ITM Isotopen Technologien M?nchen AG Details
7.1.2 ITM Isotopen Technologien M?nchen AG Major Business
7.1.3 ITM Isotopen Technologien M?nchen AG Radiotheranostic Product and Services
7.1.4 ITM Isotopen Technologien M?nchen AG Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 ITM Isotopen Technologien M?nchen AG Recent Developments/Updates
7.1.6 ITM Isotopen Technologien M?nchen AG Competitive Strengths & Weaknesses
7.2 Advanced Accelerator Applications
7.2.1 Advanced Accelerator Applications Details
7.2.2 Advanced Accelerator Applications Major Business
7.2.3 Advanced Accelerator Applications Radiotheranostic Product and Services
7.2.4 Advanced Accelerator Applications Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Advanced Accelerator Applications Recent Developments/Updates
7.2.6 Advanced Accelerator Applications Competitive Strengths & Weaknesses
7.3 Telix Pharmaceuticals
7.3.1 Telix Pharmaceuticals Details
7.3.2 Telix Pharmaceuticals Major Business
7.3.3 Telix Pharmaceuticals Radiotheranostic Product and Services
7.3.4 Telix Pharmaceuticals Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Telix Pharmaceuticals Recent Developments/Updates
7.3.6 Telix Pharmaceuticals Competitive Strengths & Weaknesses
7.4 Theragnostics Ltd.
7.4.1 Theragnostics Ltd. Details
7.4.2 Theragnostics Ltd. Major Business
7.4.3 Theragnostics Ltd. Radiotheranostic Product and Services
7.4.4 Theragnostics Ltd. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Theragnostics Ltd. Recent Developments/Updates
7.4.6 Theragnostics Ltd. Competitive Strengths & Weaknesses
7.5 NuView Life Sciences
7.5.1 NuView Life Sciences Details
7.5.2 NuView Life Sciences Major Business
7.5.3 NuView Life Sciences Radiotheranostic Product and Services
7.5.4 NuView Life Sciences Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 NuView Life Sciences Recent Developments/Updates
7.5.6 NuView Life Sciences Competitive Strengths & Weaknesses
7.6 Jubilant Pharma Limited
7.6.1 Jubilant Pharma Limited Details
7.6.2 Jubilant Pharma Limited Major Business
7.6.3 Jubilant Pharma Limited Radiotheranostic Product and Services
7.6.4 Jubilant Pharma Limited Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Jubilant Pharma Limited Recent Developments/Updates
7.6.6 Jubilant Pharma Limited Competitive Strengths & Weaknesses
7.7 Clarity Pharmaceuticals.
7.7.1 Clarity Pharmaceuticals. Details
7.7.2 Clarity Pharmaceuticals. Major Business
7.7.3 Clarity Pharmaceuticals. Radiotheranostic Product and Services
7.7.4 Clarity Pharmaceuticals. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Clarity Pharmaceuticals. Recent Developments/Updates
7.7.6 Clarity Pharmaceuticals. Competitive Strengths & Weaknesses
7.8 TransCode Therapeutics, Inc.
7.8.1 TransCode Therapeutics, Inc. Details
7.8.2 TransCode Therapeutics, Inc. Major Business
7.8.3 TransCode Therapeutics, Inc. Radiotheranostic Product and Services
7.8.4 TransCode Therapeutics, Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 TransCode Therapeutics, Inc. Recent Developments/Updates
7.8.6 TransCode Therapeutics, Inc. Competitive Strengths & Weaknesses
7.9 Curium SAS
7.9.1 Curium SAS Details
7.9.2 Curium SAS Major Business
7.9.3 Curium SAS Radiotheranostic Product and Services
7.9.4 Curium SAS Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Curium SAS Recent Developments/Updates
7.9.6 Curium SAS Competitive Strengths & Weaknesses
7.10 GE Healthcare Inc.
7.10.1 GE Healthcare Inc. Details
7.10.2 GE Healthcare Inc. Major Business
7.10.3 GE Healthcare Inc. Radiotheranostic Product and Services
7.10.4 GE Healthcare Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 GE Healthcare Inc. Recent Developments/Updates
7.10.6 GE Healthcare Inc. Competitive Strengths & Weaknesses
7.11 Bayer AG
7.11.1 Bayer AG Details
7.11.2 Bayer AG Major Business
7.11.3 Bayer AG Radiotheranostic Product and Services
7.11.4 Bayer AG Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Bayer AG Recent Developments/Updates
7.11.6 Bayer AG Competitive Strengths & Weaknesses
7.12 Lantheus Medical
7.12.1 Lantheus Medical Details
7.12.2 Lantheus Medical Major Business
7.12.3 Lantheus Medical Radiotheranostic Product and Services
7.12.4 Lantheus Medical Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Lantheus Medical Recent Developments/Updates
7.12.6 Lantheus Medical Competitive Strengths & Weaknesses
7.13 Imaging, Inc.
7.13.1 Imaging, Inc. Details
7.13.2 Imaging, Inc. Major Business
7.13.3 Imaging, Inc. Radiotheranostic Product and Services
7.13.4 Imaging, Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Imaging, Inc. Recent Developments/Updates
7.13.6 Imaging, Inc. Competitive Strengths & Weaknesses
7.14 Novartis AG
7.14.1 Novartis AG Details
7.14.2 Novartis AG Major Business
7.14.3 Novartis AG Radiotheranostic Product and Services
7.14.4 Novartis AG Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Novartis AG Recent Developments/Updates
7.14.6 Novartis AG Competitive Strengths & Weaknesses
7.15 Spectrum Pharmaceuticals, Inc.
7.15.1 Spectrum Pharmaceuticals, Inc. Details
7.15.2 Spectrum Pharmaceuticals, Inc. Major Business
7.15.3 Spectrum Pharmaceuticals, Inc. Radiotheranostic Product and Services
7.15.4 Spectrum Pharmaceuticals, Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Spectrum Pharmaceuticals, Inc. Recent Developments/Updates
7.15.6 Spectrum Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
7.16 Ipsen S.A.
7.16.1 Ipsen S.A. Details
7.16.2 Ipsen S.A. Major Business
7.16.3 Ipsen S.A. Radiotheranostic Product and Services
7.16.4 Ipsen S.A. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Ipsen S.A. Recent Developments/Updates
7.16.6 Ipsen S.A. Competitive Strengths & Weaknesses
7.17 Actinium Pharmaceuticals, Inc. (ATNM)
7.17.1 Actinium Pharmaceuticals, Inc. (ATNM) Details
7.17.2 Actinium Pharmaceuticals, Inc. (ATNM) Major Business
7.17.3 Actinium Pharmaceuticals, Inc. (ATNM) Radiotheranostic Product and Services
7.17.4 Actinium Pharmaceuticals, Inc. (ATNM) Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Actinium Pharmaceuticals, Inc. (ATNM) Recent Developments/Updates
7.17.6 Actinium Pharmaceuticals, Inc. (ATNM) Competitive Strengths & Weaknesses
7.18 Nordic Nanovector ASA
7.18.1 Nordic Nanovector ASA Details
7.18.2 Nordic Nanovector ASA Major Business
7.18.3 Nordic Nanovector ASA Radiotheranostic Product and Services
7.18.4 Nordic Nanovector ASA Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Nordic Nanovector ASA Recent Developments/Updates
7.18.6 Nordic Nanovector ASA Competitive Strengths & Weaknesses
7.19 Y-mAbs Therapeutics, Inc.
7.19.1 Y-mAbs Therapeutics, Inc. Details
7.19.2 Y-mAbs Therapeutics, Inc. Major Business
7.19.3 Y-mAbs Therapeutics, Inc. Radiotheranostic Product and Services
7.19.4 Y-mAbs Therapeutics, Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Y-mAbs Therapeutics, Inc. Recent Developments/Updates
7.19.6 Y-mAbs Therapeutics, Inc. Competitive Strengths & Weaknesses
7.20 Sofie Biosciences, Inc.
7.20.1 Sofie Biosciences, Inc. Details
7.20.2 Sofie Biosciences, Inc. Major Business
7.20.3 Sofie Biosciences, Inc. Radiotheranostic Product and Services
7.20.4 Sofie Biosciences, Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 Sofie Biosciences, Inc. Recent Developments/Updates
7.20.6 Sofie Biosciences, Inc. Competitive Strengths & Weaknesses
7.21 Terumo Corporation
7.21.1 Terumo Corporation Details
7.21.2 Terumo Corporation Major Business
7.21.3 Terumo Corporation Radiotheranostic Product and Services
7.21.4 Terumo Corporation Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.21.5 Terumo Corporation Recent Developments/Updates
7.21.6 Terumo Corporation Competitive Strengths & Weaknesses
7.22 Sirtex Medical Limited
7.22.1 Sirtex Medical Limited Details
7.22.2 Sirtex Medical Limited Major Business
7.22.3 Sirtex Medical Limited Radiotheranostic Product and Services
7.22.4 Sirtex Medical Limited Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.22.5 Sirtex Medical Limited Recent Developments/Updates
7.22.6 Sirtex Medical Limited Competitive Strengths & Weaknesses
7.23 Boston Scientific Corporation
7.23.1 Boston Scientific Corporation Details
7.23.2 Boston Scientific Corporation Major Business
7.23.3 Boston Scientific Corporation Radiotheranostic Product and Services
7.23.4 Boston Scientific Corporation Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.23.5 Boston Scientific Corporation Recent Developments/Updates
7.23.6 Boston Scientific Corporation Competitive Strengths & Weaknesses
7.24 Nihon Medi-Physics
7.24.1 Nihon Medi-Physics Details
7.24.2 Nihon Medi-Physics Major Business
7.24.3 Nihon Medi-Physics Radiotheranostic Product and Services
7.24.4 Nihon Medi-Physics Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
7.24.5 Nihon Medi-Physics Recent Developments/Updates
7.24.6 Nihon Medi-Physics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Radiotheranostic Industry Chain
8.2 Radiotheranostic Upstream Analysis
8.3 Radiotheranostic Midstream Analysis
8.4 Radiotheranostic Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Radiotheranostic Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Radiotheranostic Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Radiotheranostic Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Radiotheranostic Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Radiotheranostic Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Radiotheranostic Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Radiotheranostic Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Radiotheranostic Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Radiotheranostic Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Radiotheranostic Players in 2022
Table 12. World Radiotheranostic Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Radiotheranostic Company Evaluation Quadrant
Table 14. Head Office of Key Radiotheranostic Player
Table 15. Radiotheranostic Market: Company Product Type Footprint
Table 16. Radiotheranostic Market: Company Product Application Footprint
Table 17. Radiotheranostic Mergers & Acquisitions Activity
Table 18. United States VS China Radiotheranostic Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Radiotheranostic Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Radiotheranostic Companies, Headquarters (States, Country)
Table 21. United States Based Companies Radiotheranostic Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Radiotheranostic Revenue Market Share (2018-2023)
Table 23. China Based Radiotheranostic Companies, Headquarters (Province, Country)
Table 24. China Based Companies Radiotheranostic Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Radiotheranostic Revenue Market Share (2018-2023)
Table 26. Rest of World Based Radiotheranostic Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Radiotheranostic Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Radiotheranostic Revenue Market Share (2018-2023)
Table 29. World Radiotheranostic Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Radiotheranostic Market Size by Type (2018-2023) & (USD Million)
Table 31. World Radiotheranostic Market Size by Type (2024-2029) & (USD Million)
Table 32. World Radiotheranostic Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Radiotheranostic Market Size by Application (2018-2023) & (USD Million)
Table 34. World Radiotheranostic Market Size by Application (2024-2029) & (USD Million)
Table 35. ITM Isotopen Technologien M?nchen AG Basic Information, Area Served and Competitors
Table 36. ITM Isotopen Technologien M?nchen AG Major Business
Table 37. ITM Isotopen Technologien M?nchen AG Radiotheranostic Product and Services
Table 38. ITM Isotopen Technologien M?nchen AG Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. ITM Isotopen Technologien M?nchen AG Recent Developments/Updates
Table 40. ITM Isotopen Technologien M?nchen AG Competitive Strengths & Weaknesses
Table 41. Advanced Accelerator Applications Basic Information, Area Served and Competitors
Table 42. Advanced Accelerator Applications Major Business
Table 43. Advanced Accelerator Applications Radiotheranostic Product and Services
Table 44. Advanced Accelerator Applications Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Advanced Accelerator Applications Recent Developments/Updates
Table 46. Advanced Accelerator Applications Competitive Strengths & Weaknesses
Table 47. Telix Pharmaceuticals Basic Information, Area Served and Competitors
Table 48. Telix Pharmaceuticals Major Business
Table 49. Telix Pharmaceuticals Radiotheranostic Product and Services
Table 50. Telix Pharmaceuticals Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Telix Pharmaceuticals Recent Developments/Updates
Table 52. Telix Pharmaceuticals Competitive Strengths & Weaknesses
Table 53. Theragnostics Ltd. Basic Information, Area Served and Competitors
Table 54. Theragnostics Ltd. Major Business
Table 55. Theragnostics Ltd. Radiotheranostic Product and Services
Table 56. Theragnostics Ltd. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Theragnostics Ltd. Recent Developments/Updates
Table 58. Theragnostics Ltd. Competitive Strengths & Weaknesses
Table 59. NuView Life Sciences Basic Information, Area Served and Competitors
Table 60. NuView Life Sciences Major Business
Table 61. NuView Life Sciences Radiotheranostic Product and Services
Table 62. NuView Life Sciences Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. NuView Life Sciences Recent Developments/Updates
Table 64. NuView Life Sciences Competitive Strengths & Weaknesses
Table 65. Jubilant Pharma Limited Basic Information, Area Served and Competitors
Table 66. Jubilant Pharma Limited Major Business
Table 67. Jubilant Pharma Limited Radiotheranostic Product and Services
Table 68. Jubilant Pharma Limited Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Jubilant Pharma Limited Recent Developments/Updates
Table 70. Jubilant Pharma Limited Competitive Strengths & Weaknesses
Table 71. Clarity Pharmaceuticals. Basic Information, Area Served and Competitors
Table 72. Clarity Pharmaceuticals. Major Business
Table 73. Clarity Pharmaceuticals. Radiotheranostic Product and Services
Table 74. Clarity Pharmaceuticals. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Clarity Pharmaceuticals. Recent Developments/Updates
Table 76. Clarity Pharmaceuticals. Competitive Strengths & Weaknesses
Table 77. TransCode Therapeutics, Inc. Basic Information, Area Served and Competitors
Table 78. TransCode Therapeutics, Inc. Major Business
Table 79. TransCode Therapeutics, Inc. Radiotheranostic Product and Services
Table 80. TransCode Therapeutics, Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. TransCode Therapeutics, Inc. Recent Developments/Updates
Table 82. TransCode Therapeutics, Inc. Competitive Strengths & Weaknesses
Table 83. Curium SAS Basic Information, Area Served and Competitors
Table 84. Curium SAS Major Business
Table 85. Curium SAS Radiotheranostic Product and Services
Table 86. Curium SAS Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Curium SAS Recent Developments/Updates
Table 88. Curium SAS Competitive Strengths & Weaknesses
Table 89. GE Healthcare Inc. Basic Information, Area Served and Competitors
Table 90. GE Healthcare Inc. Major Business
Table 91. GE Healthcare Inc. Radiotheranostic Product and Services
Table 92. GE Healthcare Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. GE Healthcare Inc. Recent Developments/Updates
Table 94. GE Healthcare Inc. Competitive Strengths & Weaknesses
Table 95. Bayer AG Basic Information, Area Served and Competitors
Table 96. Bayer AG Major Business
Table 97. Bayer AG Radiotheranostic Product and Services
Table 98. Bayer AG Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Bayer AG Recent Developments/Updates
Table 100. Bayer AG Competitive Strengths & Weaknesses
Table 101. Lantheus Medical Basic Information, Area Served and Competitors
Table 102. Lantheus Medical Major Business
Table 103. Lantheus Medical Radiotheranostic Product and Services
Table 104. Lantheus Medical Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Lantheus Medical Recent Developments/Updates
Table 106. Lantheus Medical Competitive Strengths & Weaknesses
Table 107. Imaging, Inc. Basic Information, Area Served and Competitors
Table 108. Imaging, Inc. Major Business
Table 109. Imaging, Inc. Radiotheranostic Product and Services
Table 110. Imaging, Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Imaging, Inc. Recent Developments/Updates
Table 112. Imaging, Inc. Competitive Strengths & Weaknesses
Table 113. Novartis AG Basic Information, Area Served and Competitors
Table 114. Novartis AG Major Business
Table 115. Novartis AG Radiotheranostic Product and Services
Table 116. Novartis AG Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Novartis AG Recent Developments/Updates
Table 118. Novartis AG Competitive Strengths & Weaknesses
Table 119. Spectrum Pharmaceuticals, Inc. Basic Information, Area Served and Competitors
Table 120. Spectrum Pharmaceuticals, Inc. Major Business
Table 121. Spectrum Pharmaceuticals, Inc. Radiotheranostic Product and Services
Table 122. Spectrum Pharmaceuticals, Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Spectrum Pharmaceuticals, Inc. Recent Developments/Updates
Table 124. Spectrum Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
Table 125. Ipsen S.A. Basic Information, Area Served and Competitors
Table 126. Ipsen S.A. Major Business
Table 127. Ipsen S.A. Radiotheranostic Product and Services
Table 128. Ipsen S.A. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Ipsen S.A. Recent Developments/Updates
Table 130. Ipsen S.A. Competitive Strengths & Weaknesses
Table 131. Actinium Pharmaceuticals, Inc. (ATNM) Basic Information, Area Served and Competitors
Table 132. Actinium Pharmaceuticals, Inc. (ATNM) Major Business
Table 133. Actinium Pharmaceuticals, Inc. (ATNM) Radiotheranostic Product and Services
Table 134. Actinium Pharmaceuticals, Inc. (ATNM) Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Actinium Pharmaceuticals, Inc. (ATNM) Recent Developments/Updates
Table 136. Actinium Pharmaceuticals, Inc. (ATNM) Competitive Strengths & Weaknesses
Table 137. Nordic Nanovector ASA Basic Information, Area Served and Competitors
Table 138. Nordic Nanovector ASA Major Business
Table 139. Nordic Nanovector ASA Radiotheranostic Product and Services
Table 140. Nordic Nanovector ASA Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Nordic Nanovector ASA Recent Developments/Updates
Table 142. Nordic Nanovector ASA Competitive Strengths & Weaknesses
Table 143. Y-mAbs Therapeutics, Inc. Basic Information, Area Served and Competitors
Table 144. Y-mAbs Therapeutics, Inc. Major Business
Table 145. Y-mAbs Therapeutics, Inc. Radiotheranostic Product and Services
Table 146. Y-mAbs Therapeutics, Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Y-mAbs Therapeutics, Inc. Recent Developments/Updates
Table 148. Y-mAbs Therapeutics, Inc. Competitive Strengths & Weaknesses
Table 149. Sofie Biosciences, Inc. Basic Information, Area Served and Competitors
Table 150. Sofie Biosciences, Inc. Major Business
Table 151. Sofie Biosciences, Inc. Radiotheranostic Product and Services
Table 152. Sofie Biosciences, Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 153. Sofie Biosciences, Inc. Recent Developments/Updates
Table 154. Sofie Biosciences, Inc. Competitive Strengths & Weaknesses
Table 155. Terumo Corporation Basic Information, Area Served and Competitors
Table 156. Terumo Corporation Major Business
Table 157. Terumo Corporation Radiotheranostic Product and Services
Table 158. Terumo Corporation Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 159. Terumo Corporation Recent Developments/Updates
Table 160. Terumo Corporation Competitive Strengths & Weaknesses
Table 161. Sirtex Medical Limited Basic Information, Area Served and Competitors
Table 162. Sirtex Medical Limited Major Business
Table 163. Sirtex Medical Limited Radiotheranostic Product and Services
Table 164. Sirtex Medical Limited Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 165. Sirtex Medical Limited Recent Developments/Updates
Table 166. Sirtex Medical Limited Competitive Strengths & Weaknesses
Table 167. Boston Scientific Corporation Basic Information, Area Served and Competitors
Table 168. Boston Scientific Corporation Major Business
Table 169. Boston Scientific Corporation Radiotheranostic Product and Services
Table 170. Boston Scientific Corporation Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 171. Boston Scientific Corporation Recent Developments/Updates
Table 172. Nihon Medi-Physics Basic Information, Area Served and Competitors
Table 173. Nihon Medi-Physics Major Business
Table 174. Nihon Medi-Physics Radiotheranostic Product and Services
Table 175. Nihon Medi-Physics Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 176. Global Key Players of Radiotheranostic Upstream (Raw Materials)
Table 177. Radiotheranostic Typical Customers
Table 1. World Radiotheranostic Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Radiotheranostic Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Radiotheranostic Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Radiotheranostic Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Radiotheranostic Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Radiotheranostic Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Radiotheranostic Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Radiotheranostic Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Radiotheranostic Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Radiotheranostic Players in 2022
Table 12. World Radiotheranostic Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Radiotheranostic Company Evaluation Quadrant
Table 14. Head Office of Key Radiotheranostic Player
Table 15. Radiotheranostic Market: Company Product Type Footprint
Table 16. Radiotheranostic Market: Company Product Application Footprint
Table 17. Radiotheranostic Mergers & Acquisitions Activity
Table 18. United States VS China Radiotheranostic Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Radiotheranostic Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Radiotheranostic Companies, Headquarters (States, Country)
Table 21. United States Based Companies Radiotheranostic Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Radiotheranostic Revenue Market Share (2018-2023)
Table 23. China Based Radiotheranostic Companies, Headquarters (Province, Country)
Table 24. China Based Companies Radiotheranostic Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Radiotheranostic Revenue Market Share (2018-2023)
Table 26. Rest of World Based Radiotheranostic Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Radiotheranostic Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Radiotheranostic Revenue Market Share (2018-2023)
Table 29. World Radiotheranostic Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Radiotheranostic Market Size by Type (2018-2023) & (USD Million)
Table 31. World Radiotheranostic Market Size by Type (2024-2029) & (USD Million)
Table 32. World Radiotheranostic Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Radiotheranostic Market Size by Application (2018-2023) & (USD Million)
Table 34. World Radiotheranostic Market Size by Application (2024-2029) & (USD Million)
Table 35. ITM Isotopen Technologien M?nchen AG Basic Information, Area Served and Competitors
Table 36. ITM Isotopen Technologien M?nchen AG Major Business
Table 37. ITM Isotopen Technologien M?nchen AG Radiotheranostic Product and Services
Table 38. ITM Isotopen Technologien M?nchen AG Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. ITM Isotopen Technologien M?nchen AG Recent Developments/Updates
Table 40. ITM Isotopen Technologien M?nchen AG Competitive Strengths & Weaknesses
Table 41. Advanced Accelerator Applications Basic Information, Area Served and Competitors
Table 42. Advanced Accelerator Applications Major Business
Table 43. Advanced Accelerator Applications Radiotheranostic Product and Services
Table 44. Advanced Accelerator Applications Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Advanced Accelerator Applications Recent Developments/Updates
Table 46. Advanced Accelerator Applications Competitive Strengths & Weaknesses
Table 47. Telix Pharmaceuticals Basic Information, Area Served and Competitors
Table 48. Telix Pharmaceuticals Major Business
Table 49. Telix Pharmaceuticals Radiotheranostic Product and Services
Table 50. Telix Pharmaceuticals Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Telix Pharmaceuticals Recent Developments/Updates
Table 52. Telix Pharmaceuticals Competitive Strengths & Weaknesses
Table 53. Theragnostics Ltd. Basic Information, Area Served and Competitors
Table 54. Theragnostics Ltd. Major Business
Table 55. Theragnostics Ltd. Radiotheranostic Product and Services
Table 56. Theragnostics Ltd. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Theragnostics Ltd. Recent Developments/Updates
Table 58. Theragnostics Ltd. Competitive Strengths & Weaknesses
Table 59. NuView Life Sciences Basic Information, Area Served and Competitors
Table 60. NuView Life Sciences Major Business
Table 61. NuView Life Sciences Radiotheranostic Product and Services
Table 62. NuView Life Sciences Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. NuView Life Sciences Recent Developments/Updates
Table 64. NuView Life Sciences Competitive Strengths & Weaknesses
Table 65. Jubilant Pharma Limited Basic Information, Area Served and Competitors
Table 66. Jubilant Pharma Limited Major Business
Table 67. Jubilant Pharma Limited Radiotheranostic Product and Services
Table 68. Jubilant Pharma Limited Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Jubilant Pharma Limited Recent Developments/Updates
Table 70. Jubilant Pharma Limited Competitive Strengths & Weaknesses
Table 71. Clarity Pharmaceuticals. Basic Information, Area Served and Competitors
Table 72. Clarity Pharmaceuticals. Major Business
Table 73. Clarity Pharmaceuticals. Radiotheranostic Product and Services
Table 74. Clarity Pharmaceuticals. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Clarity Pharmaceuticals. Recent Developments/Updates
Table 76. Clarity Pharmaceuticals. Competitive Strengths & Weaknesses
Table 77. TransCode Therapeutics, Inc. Basic Information, Area Served and Competitors
Table 78. TransCode Therapeutics, Inc. Major Business
Table 79. TransCode Therapeutics, Inc. Radiotheranostic Product and Services
Table 80. TransCode Therapeutics, Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. TransCode Therapeutics, Inc. Recent Developments/Updates
Table 82. TransCode Therapeutics, Inc. Competitive Strengths & Weaknesses
Table 83. Curium SAS Basic Information, Area Served and Competitors
Table 84. Curium SAS Major Business
Table 85. Curium SAS Radiotheranostic Product and Services
Table 86. Curium SAS Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Curium SAS Recent Developments/Updates
Table 88. Curium SAS Competitive Strengths & Weaknesses
Table 89. GE Healthcare Inc. Basic Information, Area Served and Competitors
Table 90. GE Healthcare Inc. Major Business
Table 91. GE Healthcare Inc. Radiotheranostic Product and Services
Table 92. GE Healthcare Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. GE Healthcare Inc. Recent Developments/Updates
Table 94. GE Healthcare Inc. Competitive Strengths & Weaknesses
Table 95. Bayer AG Basic Information, Area Served and Competitors
Table 96. Bayer AG Major Business
Table 97. Bayer AG Radiotheranostic Product and Services
Table 98. Bayer AG Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Bayer AG Recent Developments/Updates
Table 100. Bayer AG Competitive Strengths & Weaknesses
Table 101. Lantheus Medical Basic Information, Area Served and Competitors
Table 102. Lantheus Medical Major Business
Table 103. Lantheus Medical Radiotheranostic Product and Services
Table 104. Lantheus Medical Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Lantheus Medical Recent Developments/Updates
Table 106. Lantheus Medical Competitive Strengths & Weaknesses
Table 107. Imaging, Inc. Basic Information, Area Served and Competitors
Table 108. Imaging, Inc. Major Business
Table 109. Imaging, Inc. Radiotheranostic Product and Services
Table 110. Imaging, Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Imaging, Inc. Recent Developments/Updates
Table 112. Imaging, Inc. Competitive Strengths & Weaknesses
Table 113. Novartis AG Basic Information, Area Served and Competitors
Table 114. Novartis AG Major Business
Table 115. Novartis AG Radiotheranostic Product and Services
Table 116. Novartis AG Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Novartis AG Recent Developments/Updates
Table 118. Novartis AG Competitive Strengths & Weaknesses
Table 119. Spectrum Pharmaceuticals, Inc. Basic Information, Area Served and Competitors
Table 120. Spectrum Pharmaceuticals, Inc. Major Business
Table 121. Spectrum Pharmaceuticals, Inc. Radiotheranostic Product and Services
Table 122. Spectrum Pharmaceuticals, Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Spectrum Pharmaceuticals, Inc. Recent Developments/Updates
Table 124. Spectrum Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
Table 125. Ipsen S.A. Basic Information, Area Served and Competitors
Table 126. Ipsen S.A. Major Business
Table 127. Ipsen S.A. Radiotheranostic Product and Services
Table 128. Ipsen S.A. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Ipsen S.A. Recent Developments/Updates
Table 130. Ipsen S.A. Competitive Strengths & Weaknesses
Table 131. Actinium Pharmaceuticals, Inc. (ATNM) Basic Information, Area Served and Competitors
Table 132. Actinium Pharmaceuticals, Inc. (ATNM) Major Business
Table 133. Actinium Pharmaceuticals, Inc. (ATNM) Radiotheranostic Product and Services
Table 134. Actinium Pharmaceuticals, Inc. (ATNM) Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Actinium Pharmaceuticals, Inc. (ATNM) Recent Developments/Updates
Table 136. Actinium Pharmaceuticals, Inc. (ATNM) Competitive Strengths & Weaknesses
Table 137. Nordic Nanovector ASA Basic Information, Area Served and Competitors
Table 138. Nordic Nanovector ASA Major Business
Table 139. Nordic Nanovector ASA Radiotheranostic Product and Services
Table 140. Nordic Nanovector ASA Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Nordic Nanovector ASA Recent Developments/Updates
Table 142. Nordic Nanovector ASA Competitive Strengths & Weaknesses
Table 143. Y-mAbs Therapeutics, Inc. Basic Information, Area Served and Competitors
Table 144. Y-mAbs Therapeutics, Inc. Major Business
Table 145. Y-mAbs Therapeutics, Inc. Radiotheranostic Product and Services
Table 146. Y-mAbs Therapeutics, Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Y-mAbs Therapeutics, Inc. Recent Developments/Updates
Table 148. Y-mAbs Therapeutics, Inc. Competitive Strengths & Weaknesses
Table 149. Sofie Biosciences, Inc. Basic Information, Area Served and Competitors
Table 150. Sofie Biosciences, Inc. Major Business
Table 151. Sofie Biosciences, Inc. Radiotheranostic Product and Services
Table 152. Sofie Biosciences, Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 153. Sofie Biosciences, Inc. Recent Developments/Updates
Table 154. Sofie Biosciences, Inc. Competitive Strengths & Weaknesses
Table 155. Terumo Corporation Basic Information, Area Served and Competitors
Table 156. Terumo Corporation Major Business
Table 157. Terumo Corporation Radiotheranostic Product and Services
Table 158. Terumo Corporation Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 159. Terumo Corporation Recent Developments/Updates
Table 160. Terumo Corporation Competitive Strengths & Weaknesses
Table 161. Sirtex Medical Limited Basic Information, Area Served and Competitors
Table 162. Sirtex Medical Limited Major Business
Table 163. Sirtex Medical Limited Radiotheranostic Product and Services
Table 164. Sirtex Medical Limited Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 165. Sirtex Medical Limited Recent Developments/Updates
Table 166. Sirtex Medical Limited Competitive Strengths & Weaknesses
Table 167. Boston Scientific Corporation Basic Information, Area Served and Competitors
Table 168. Boston Scientific Corporation Major Business
Table 169. Boston Scientific Corporation Radiotheranostic Product and Services
Table 170. Boston Scientific Corporation Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 171. Boston Scientific Corporation Recent Developments/Updates
Table 172. Nihon Medi-Physics Basic Information, Area Served and Competitors
Table 173. Nihon Medi-Physics Major Business
Table 174. Nihon Medi-Physics Radiotheranostic Product and Services
Table 175. Nihon Medi-Physics Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 176. Global Key Players of Radiotheranostic Upstream (Raw Materials)
Table 177. Radiotheranostic Typical Customers
LIST OF FIGURES
Figure 1. Radiotheranostic Picture
Figure 2. World Radiotheranostic Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Radiotheranostic Total Market Size (2018-2029) & (USD Million)
Figure 4. World Radiotheranostic Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Radiotheranostic Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Radiotheranostic Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Radiotheranostic Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Radiotheranostic Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Radiotheranostic Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Radiotheranostic Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Radiotheranostic Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Radiotheranostic Revenue (2018-2029) & (USD Million)
Figure 13. Radiotheranostic Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Radiotheranostic Consumption Value (2018-2029) & (USD Million)
Figure 16. World Radiotheranostic Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Radiotheranostic Consumption Value (2018-2029) & (USD Million)
Figure 18. China Radiotheranostic Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Radiotheranostic Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Radiotheranostic Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Radiotheranostic Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Radiotheranostic Consumption Value (2018-2029) & (USD Million)
Figure 23. India Radiotheranostic Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Radiotheranostic by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Radiotheranostic Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Radiotheranostic Markets in 2022
Figure 27. United States VS China: Radiotheranostic Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Radiotheranostic Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Radiotheranostic Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Radiotheranostic Market Size Market Share by Type in 2022
Figure 31. Nuclear Reactors
Figure 32. Cyclotrons
Figure 33. World Radiotheranostic Market Size Market Share by Type (2018-2029)
Figure 34. World Radiotheranostic Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Radiotheranostic Market Size Market Share by Application in 2022
Figure 36. Oncology
Figure 37. Non-Oncology
Figure 38. Radiotheranostic Industrial Chain
Figure 39. Methodology
Figure 40. Research Process and Data Source
Figure 1. Radiotheranostic Picture
Figure 2. World Radiotheranostic Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Radiotheranostic Total Market Size (2018-2029) & (USD Million)
Figure 4. World Radiotheranostic Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Radiotheranostic Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Radiotheranostic Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Radiotheranostic Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Radiotheranostic Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Radiotheranostic Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Radiotheranostic Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Radiotheranostic Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Radiotheranostic Revenue (2018-2029) & (USD Million)
Figure 13. Radiotheranostic Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Radiotheranostic Consumption Value (2018-2029) & (USD Million)
Figure 16. World Radiotheranostic Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Radiotheranostic Consumption Value (2018-2029) & (USD Million)
Figure 18. China Radiotheranostic Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Radiotheranostic Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Radiotheranostic Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Radiotheranostic Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Radiotheranostic Consumption Value (2018-2029) & (USD Million)
Figure 23. India Radiotheranostic Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Radiotheranostic by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Radiotheranostic Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Radiotheranostic Markets in 2022
Figure 27. United States VS China: Radiotheranostic Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Radiotheranostic Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Radiotheranostic Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Radiotheranostic Market Size Market Share by Type in 2022
Figure 31. Nuclear Reactors
Figure 32. Cyclotrons
Figure 33. World Radiotheranostic Market Size Market Share by Type (2018-2029)
Figure 34. World Radiotheranostic Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Radiotheranostic Market Size Market Share by Application in 2022
Figure 36. Oncology
Figure 37. Non-Oncology
Figure 38. Radiotheranostic Industrial Chain
Figure 39. Methodology
Figure 40. Research Process and Data Source
